SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Genmab at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Genmab brings 3 presentations to SITC 2026 in Phoenix. Its program centres on clinical data for immune cell engagers, bispecific antibodies and antibody-drug conjugates. A concrete study of breast cancer biopsies finds that tumors already inflamed with immune activity are more sensitive to antibody-drug conjugates such as T-DXd and Sac-Gov.

OrganizationSITC 2026 Attendance
Genmab
Copenhagen, Denmark
Biotech
Danish antibody company with marketed cancer medicines, developing bispecific antibodies and antibody-drug conjugates.
Talk
Thu Nov 5
10:40am–10:50am
Talk
Thu Nov 5
2:25pm–2:35pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Genmab

Tell us what you sell and we’ll find the people at Genmab most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction